Danielle S. Wallace

Danielle S. Wallace, M.D., is an Assistant Professor at the University of Rochester School of Medicine and Dentistry, affiliated with the Department of Medicine, Hematology/Oncology. As a clinician researcher, she specializes in the treatment of lymphoma, with a focus on nodal and cutaneous T-cell lymphomas, and is actively involved in clinical trials for cellular therapies like CAR T-cell treatment.

• MD | SUNY Upstate Medical University College of Medicine, 2016
• Fellowship, Hematology & Oncology, University of Rochester Medical Center, 2020-2023
• Residency, Internal Medicine, University of Rochester Medical Center, 2017-2019
• Certified by American Board of Internal Medicine in Hematology, Internal Medicine, and Medical Oncology

Her research emphasizes lymphoma treatment optimization, molecular classification, and targeted therapies. She leads clinical trials such as a Phase 2 Study of Epcoritamab and Rituximab for Follicular Lymphoma and a Randomized Phase 3 Trial of Zanubrutinib for Mantle Cell Lymphoma. Her work spans clinical trials, biomarker analysis, and patient-centered care in immune-privileged sites.

Scientific awards include:

• Wilmot Physician Scientist-Fellowship Program (2025-2028)
• Wilmot Investigator Initiated Trial Support Program (2025-2027)
• Lymphoma Scientific Research Mentoring Program (2024-2026)
• Arnold P. Gold Foundation Humanism and Excellence in Teaching Award (2018)

She is part of the multidisciplinary team at Wilmot Cancer Center, collaborating with clinical trial offices, radiation oncologists, and pathologists to enhance patient experiences. Her grants focus on hematologic malignancies, innovative therapies, and medical education initiatives.